Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in KoreaJin Myoung Seok, Ju‐Hong Min, Hye-Jin Cho et al.|Multiple Sclerosis Journal|2017Cited by 82
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Sung Min Kim, Hyunjin Kim et al.|JAMA Neurology|2024Cited by 26
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrumSu Yeon Park, Young Nam Kwon, Sun‐Young Kim et al.|Journal of Neurology Neurosurgery & Psychiatry|2023Cited by 18
Export of Diverse and Bioactive Small Proteins through a Type I Secretion SystemSun‐Young Kim, Bryan W. Davies|Applied and Environmental Microbiology|2023Cited by 15
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae‐Won Hyun, Ho Jin Kim, Hye Lim Lee et al.|Multiple Sclerosis Journal|2020Cited by 14